Podcast by Professor Jonathan Blackburn, CSO and Head of R&D

October 23, 2023

What makes an ideal biomarker and how do you measure? Professor Blackburn recently shared his insights with Drug Discovery World.

Have a listen:

https://www.ddw-online.com/c/podcasts/

Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.

Design and development by RainCastle Communications.

Podcast by Professor Jonathan Blackburn, CSO and Head of R&D

Fill in the form to download the publication

Watch the video

Watch the video

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation

Read the Review

Watch the video